The social patient network CureTogether reported in February the results of study among 227 people who rated 31 treatments for bipolar disorder. It is one of the first such studies that blend social media, patient-stated outcomes with integrated therapy options.

“Patients rate regimented sleep, reduced alcohol, and exercise as helpful for their symptoms, as well as yoga, mindfulness meditation, and Lamictal*.” (more…)


Genomic testing (and personalized medicine?) runs afoul of the FDA

The Chicago Tribune reported this week that the FDA is preparing to define home genetic testing kits as “medical devices” and as such will be subject to regulation.

The FDA alerted five of the most prominent companies providing these services, including 23andme and Navigenics that, in effect, they have circumvented regulatory procedures by making DNA test kits available without submitting them to FDA procedures.    (more…)

National Cancer Institute Funds 20,000-person Trial in Early 2010

In a recently released video NCI’s Dr. John Milner, chief of the Division of Cancer Prevention’s Nutritional Science Research Group, describes how changing scientific perceptions of the medicinal power of foods and the knowledge of the human genome is influencing cancer research.

Citing “rather compelling evidence” that shows “30% of cancers are related to dietary habits,” Milner observed that in cancer-averting diets, “You must assume that those foods are supplying some bioactive food component.”

“It is an area that somehow we have thought is very simple,” he notes.  “But is not very simple.” (more…)

NCCAM’s 10th Anniversary Event Goes Deep into Human Biology
NCCAM’s symposium on Dec. 10 at NIH will include discussions of its early research projects starting to focus on the the processes of disease and illness at the microbiological level and on the neurological factors related to integrative approaches like meditation.

NCCAM Director Josephine P. Briggs, M.D. will host the day-long event that includes these topics:

Natural Products, moderated by Robert Nussenblatt, M.D., Acting Scientific and Clinical Director, Division of Intramural Research, NCCAM (more…)